XOPENEX HFA 45 ug/1
levalbuterol tartrate · AEROSOL, METERED · Lupin Pharmaceuticals, Inc.
No Recall History
Plain English
XOPENEX HFA is a aerosol, metered containing levalbuterol tartrate at 45 ug/1, taken oral. Manufactured by Lupin Pharmaceuticals, Inc..
Key Facts
- Brand Name
- XOPENEX HFA
- Generic Name
- levalbuterol tartrate
- NDC Code (Product)
27437-056- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Strength
- 45 ug/1
- Dosage Form
- AEROSOL, METERED
- Route
- ORAL
- Marketing Status
- Application #
- NDA021730
- Marketing Start
- 11/10/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is XOPENEX HFA used for?
XOPENEX HFA contains levalbuterol tartrate. It is a aerosol, metered taken oral. Consult your doctor for specific uses.
Is XOPENEX HFA a controlled substance?
XOPENEX HFA is not classified as a controlled substance by the DEA.
What is the generic name for XOPENEX HFA?
The generic name for XOPENEX HFA is levalbuterol tartrate. There are 3 other brand versions of levalbuterol tartrate.
What is the NDC code for XOPENEX HFA 45 ug/1?
The NDC (National Drug Code) for XOPENEX HFA 45 ug/1 is 27437-056, listed by Lupin Pharmaceuticals, Inc..